|
LOC646762 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.105600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.237600E-01 |
| Normal-vs-Stage2 |
2.855200E-01 |
| Normal-vs-Stage3 |
6.814200E-01 |
| Normal-vs-Stage4 |
2.465800E-01 |
| Stage1-vs-Stage2 |
5.895600E-01 |
| Stage1-vs-Stage3 |
7.399200E-01 |
| Stage1-vs-Stage4 |
3.999600E-01 |
| Stage2-vs-Stage3 |
5.091600E-01 |
| Stage2-vs-Stage4 |
7.374600E-01 |
| Stage3-vs-Stage4 |
3.546200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.983900E-02 |
| Normal-vs-AfricanAmerican |
8.306400E-02 |
| Normal-vs-Asian |
3.646600E-01 |
| Caucasian-vs-AfricanAmerican |
5.606800E-01 |
| Caucasian-vs-Asian |
5.106000E-01 |
| AfricanAmerican-vs-Asian |
4.030200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.191030E-01 |
| Normal-vs-Female |
9.796800E-03 |
| Male-vs-Female |
9.822300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.825200E-01 |
| Normal-vs-Extreme_Weight |
2.685000E-01 |
| Normal-vs-Obese |
6.784100E-02 |
| Normal-vs-Extreme_Obese |
5.117200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.347000E-01 |
| Normal_Weight-vs-Obese |
6.012600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.071200E-01 |
| Extreme_Weight-vs-Obese |
5.106800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.745400E-01 |
| Obese-vs-Extreme_Obese |
1.777560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.814180E-02 |
| Normal-vs-Age(41-60Yrs) |
5.599000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.671200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.689000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.415800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.221400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.447900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.703600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.437200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.110600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.955300E-04 |
| Normal-VS-Type2 PRCC |
6.617800E-03 |
| Normal-VS-KIRP CIMP |
1.509680E-02 |
| Normal-VS-Unclassified PRCC |
1.166570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.61990462447193E-11 |
| Type1 PRCC-VS-KIRP CIMP |
1.684050E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.447000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.917900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.003360E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.622170E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.170400E-01 |
| Normal-vs-N1 |
5.548300E-02 |
| Normal-vs-N2 |
5.542800E-01 |
| N0-vs-N1 |
1.611850E-02 |
| N0-vs-N2 |
3.848000E-01 |
| N1-vs-N2 |
5.701200E-01 |
|
|
